These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31606013)

  • 1. [The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies].
    Valle-Rodríguez F; López-García AI; Rivero-Yeverino D; Caballero-López C; Papaqui-Tapia JS; Ruiz-Márquez IP; Ríos-López JJ; Sánchez-Villalobos JY
    Rev Alerg Mex; 2019; 66(3):301-307. PubMed ID: 31606013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies after one year of treatment].
    Sánchez-Villalobos JY; Caballero-López C; López-García AI; Rivero-Yeverino D; Arana-Muñoz O; Papaqui-Tapia JS; Ríos-López JJ; Payán-Díaz JH; López-Romero CD; Villada-Villada E
    Rev Alerg Mex; 2020; 67(4):309-315. PubMed ID: 33631899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of inhalant allergen immunotherapy with mass units-standardized extracts.
    Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A
    Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis investigating the efficacy and safety of allergen-specific immunotherapy in the management of respiratory allergies.
    Li X; Shang J; Liu J; Zhu Y
    J Asthma; 2024 Oct; 61(10):1337-1346. PubMed ID: 38687911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Innovative immunotherapies of respiratory allergic diseases].
    Demoly P; Chiriac AM; Michel FB
    Bull Acad Natl Med; 2016 Mar; 200(3):545-7; discussion 557-9. PubMed ID: 28644603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen immunotherapy: present and future.
    Finegold I
    Allergy Asthma Proc; 2007; 28(1):44-9. PubMed ID: 17390757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Lin SY; Erekosima N; Kim JM; Ramanathan M; Suarez-Cuervo C; Chelladurai Y; Ward D; Segal JB
    JAMA; 2013 Mar; 309(12):1278-88. PubMed ID: 23532243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses.
    Viswanathan RK; Busse WW
    Chest; 2012 May; 141(5):1303-1314. PubMed ID: 22553263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
    Incorvaia C; Fuiano N; Leo G
    Clin Ter; 2010; 161(6):543-7. PubMed ID: 21181085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
    Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
    Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
    Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.